Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

AnteoTech Limited (ADO.AX)

Compare
0.0110
0.0000
(0.00%)
At close: 4:10:17 PM GMT+10

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Mr. David John Radford B.Sc., BSc (Hons), M.B.A., MAICD MD, CEO & Executive Director 567.81k -- --
Mr. Andrew Cook CFO & Company Secretary 318.84k -- --
Ms. Katrina Byrne Chief Operating Officer 314.25k -- --
Dr. N. Joe Maeji B.Sc., Ph.D. Founder & Chief Scientific Officer 211.47k -- --
Mr. Manuel Wieser Chief Technology Officer -- -- --
Ms. Tsui Min Lian Chief Marketing Officer -- -- --
Mr. Selahattin Guldu Executive Vice President of Commercial Banking -- -- --
Mr. Ian Steinhardt Head of Market Operations for Life Sciences -- -- --
Ms. Friederike Graser Director of Strategic Growth Initiatives -- -- --

AnteoTech Limited

Brisbane Technology Park
Unit 4 26 Brandl Street
Eight Mile Plains, QLD 4113
Australia
61 7 3219 0085 https://www.anteotech.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Corporate Governance

AnteoTech Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 25, 2025 at 11:35 PM UTC

AnteoTech Limited Earnings Date

Recent Events

Related Tickers